Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 23870911)

  • 1. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
    Szliszka E; Krol W
    Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
    Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
    Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy extract has different effects compared with the isolated isoflavones on the proteome of homocysteine-stressed endothelial cells.
    Fuchs D; Dirscherl B; Schroot JH; Daniel H; Wenzel U
    Mol Nutr Food Res; 2006 Jan; 50(1):58-69. PubMed ID: 16502433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
    Hedlund TE; Johannes WU; Miller GJ
    Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
    Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
    Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferation effect and mechanism of prostate cancer cell lines as affected by isoflavones from soybean cake.
    Wang BF; Wang JS; Lu JF; Kao TH; Chen BH
    J Agric Food Chem; 2009 Mar; 57(6):2221-32. PubMed ID: 19292464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
    Xu SZ; Zhong W; Ghavideldarestani M; Saurabh R; Lindow SW; Atkin SL
    Free Radic Biol Med; 2009 Jul; 47(2):167-75. PubMed ID: 19393315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
    Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
    Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red clover and soy isoflavones--an in vitro safety assessment.
    Reiter E; Gerster P; Jungbauer A
    Gynecol Endocrinol; 2011 Dec; 27(12):1037-42. PubMed ID: 21801124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
    Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
    Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
    Raschke M; Wähälä K; Pool-Zobel BL
    Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.
    Ajdžanović V; Mojić M; Maksimović-Ivanić D; Bulatović M; Mijatović S; Milošević V; Spasojević I
    J Membr Biol; 2013 Apr; 246(4):307-14. PubMed ID: 23417033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.
    Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT
    Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
    Chen X; Anderson JJ
    Nutr Cancer; 2001; 41(1-2):165-71. PubMed ID: 12094620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid-induced epidermal hyperplasia in human skin organ culture: inhibition with soy extract and soy isoflavones.
    Varani J; Kelley EA; Perone P; Lateef H
    Exp Mol Pathol; 2004 Dec; 77(3):176-83. PubMed ID: 15507233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.